AU Patent

AU2016213816B2 — Orally administered corticosteroid compositions

Assigned to Adare Pharma Solutions Inc · Expires 2018-03-29 · 8y expired

What this patent protects

The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an indivi…

USPTO Abstract

The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016213816B2
Jurisdiction
AU
Classification
—
Expires
2018-03-29
Drug substance claim
No
Drug product claim
No
Assignee
Adare Pharma Solutions Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.